Antiruisi Attenuates Atherosclerosis in High-Fat-Diet-Fed ApoE−/− Mice and Is Associated with Alterations in the Gut Microbiota

Atherosclerosis is a leading cause of cardiovascular morbidity and mortality, and the gut microbiota is a potential therapeutic target. Antiruisi (ATRS) is a fixed-ratio combination of natural-product-derived active ingredients. In this study, 24 male ApoE−/− mice were assigned to normal chow, high-fat diet (HFD), HFD plus atorvastatin, or HFD plus ATRS groups (n = 6 per group) and treated for 12 weeks. ATRS improved serum lipid profiles, reduced atherosclerotic plaque area, and attenuated hepatic steatosis and lipid accumulation. ATRS also altered gut microbial composition, reduced circulating trimethylamine N-oxide levels and hepatic flavin-containing monooxygenase 3 expression, modulated the farnesoid X receptor, fibroblast growth factor 15, and cholesterol 7α-hydroxylase expression, and regulated p38 mitogen-activated protein kinase and nuclear factor-kappa B expression, as well as associated inflammatory marker levels. These findings suggest that ATRS attenuates atherosclerosis in HFD-fed ApoE−/− mice, with accompanying changes in gut microbiota composition and metabolic and inflammatory markers.

Authors

Institutions

Publication Details

Journal
Journal of Cardiovascular Development and Disease
Published
2026-11-20
DOI
https://doi.org/10.3390/jcdd13110613
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antiruisi Attenuates Atherosclerosis in High-Fat-Diet-Fed ApoE−/− Mice and Is Associated with Alterations in the Gut Microbiota

Shasha Li, Zunjing Liu
3 links
Journal of Cardiovascular Development and Disease
Gut microbiota and health
article

Antiruisi Attenuates Atherosclerosis in High-Fat-Diet-Fed ApoE−/− Mice and Is Associated with Alterations in the Gut Microbiota

Shasha Li, Zunjing Liu
article en

Abstract

Atherosclerosis is a leading cause of cardiovascular morbidity and mortality, and the gut microbiota is a potential therapeutic target. Antiruisi (ATRS) is a fixed-ratio combination of natural-product-derived active ingredients. In this study, 24 male ApoE−/− mice were assigned to normal chow, high-fat diet (HFD), HFD plus atorvastatin, or HFD plus ATRS groups (n = 6 per group) and treated for 12 weeks. ATRS improved serum lipid profiles, reduced atherosclerotic plaque area, and attenuated hepatic steatosis and lipid accumulation. ATRS also altered gut microbial composition, reduced circulating trimethylamine N-oxide levels and hepatic flavin-containing monooxygenase 3 expression, modulated the farnesoid X receptor, fibroblast growth factor 15, and cholesterol 7α-hydroxylase expression, and regulated p38 mitogen-activated protein kinase and nuclear factor-kappa B expression, as well as associated inflammatory marker levels. These findings suggest that ATRS attenuates atherosclerosis in HFD-fed ApoE−/− mice, with accompanying changes in gut microbiota composition and metabolic and inflammatory markers.

Journal of Cardiovascular Development and DiseaseVol. 13(11)
Hebei Medical University (CN), Peking University People's Hospital (CN), First Affiliated Hospital of Hebei Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon